Board of Pharmacy by Cannon, K.
REGULATORY AGENCY ACTION
Regulatory Changes. The Board's
proposed amendments to section 1502 of
its regulations, which would delegate
certain Board functions to the executive
officer, was not approved by the Depart-
ment of Consumer Affairs because
Board staff failed to file a fiscal impact
statement. (See CRLR Vol. 10, Nos. 2 &
3 (Spring/Summer 1990) p. 114 for
background information.) Executive
Officer Karen Ollinger has withdrawn
the proposed rulemaking and expects to
resubmit the proposal along with the
Board's next rulemaking package.
On January 18, Board legal counsel
Steven Martini met with the Board's
president and executive officer to sort
through current proposals for changes in
the Board's regulations. (See CRLR Vol.
11, No. 1 (Winter 1991) p. 81 for back-
ground information.) The Board's regu-
lations committee was scheduled to meet
on April 10 in Sacramento to continue
its comprehensive review of the Board's
regulations.
LEGISLATION:
AB 1124 (Frizzelle), as introduced
March 5, would establish the right, duty,
responsibility, and obligation of a person
engaged in the practice of optometry to
exercise professional judgment in the
performance of his/her duties, including,
but not limited to, scheduling, diagnosis,
treatment within the scope of practice of
optometry, and referral of patients. This
bill would also prohibit a health care ser-
vice plan, and a specialized health care
service plan, that provides one or more
optometric services, from interfering
with the professional judgment of a per-
son engaged in the practice of optometry
pursuant to that plan. This bill is pending
in the Assembly Health Committee.
AB 1358 (Floyd), as introduced
March 7, would specify that a registered
optometrist who performs any act con-
stituting the practice of optometry while
employed by another optometrist, a
physician, or any entity authorized by
the laws of this state to employ an
optometrist to perform acts constituting
the practice of optometry is bound by
and subject to the optometry statutes and
regulations. This bill would also specify
that the Board may suspend or evoke
the certificate of registration of, or other-
wise discipline, an optometrist who is
employed as described above for any of
the causes specified in the optometry
statutes or regulations. This bill is pend-
ing in the Assembly Health Committee.
SB 613 (Calderon). Existing law
requires a registered optometrist who
temporarily practices optometry outside
or away from his/her regular place of
practice to deliver to each patient there
fitted or supplied with glasses a specified
receipt. As introduced March 4, this bill
would instead require a registered
optometrist to furnish to each patient
there fitted or supplied with prescription
lenses a specified receipt. This bill is
pending in the Senate Business and Pro-
fessions Committee.
AB 1046 (Tucker). Existing law
requires certain health practitioners, law
enforcement officers, and other specified
individuals to report any evidence of
abuse of an elderly or dependent person.
As introduced March 4, this bill would
add optometrists to the definition of
health practitioner for purposes of the
reporting requirements. This bill is pend-
ing in the Assembly Human Services
Committee.
LITIGATION:
On January 8, the U.S. Court of
Appeals for the District of Columbia
Circuit denied the Federal Trade Com-
mission's (FTC) petition for rehearing in
California State Board of Optometry v.
Federal Trade Commission, 910 F.2d
976 (D.C. Cir. 1990). This ruling repre-
sents a far-reaching victory for the
Board; the decision limits the FTC's
oversight over anticompetitive activities
engaged in or authorized by the Board.
(See CRLR Vol. 11, No. 1 (Winter 1991)
p. 81; Vol. 10, No. 4 (Fall 1990) pp. 97-
98; and Vol. 10, No. 1 (Winter 1990) pp.
88-89 for extensive background infor-
mation.)
The court let stand its previous deci-
sion invalidating the FTC's "Eyeglasses
II" rule, which attempted to remove
state-imposed restrictions on corporate
optometry. The FTC's petition for
rehearing argued that the Commission
may disallow those regulations issued by
state and local governmental entities that
lie outside of the "state action" scope of
the Parker v. Brown exception. Howev-
er, the court stated that the "Eyeglasses
II" rule is "fundamentally flawed"
because it is "explicitly directed at state
action," in that its "primary focus is on
'state-imposed and state-enforced
restrictions."' The court suggested that
the FTC may be able to accomplish
some of its purposes without exceeding
its rulemaking authority, such as initiat-
ing a new proceeding to challenge, with-
in the limits of its proper authority, any
practice that it believes to be unfair.
RECENT MEETINGS:
At its February 11 meeting in Sacra-
mento, the Board welcomed two new
members, optometrists Gene Calkins
and Joe Dobbs, who were appointed by
Governor Deukmejian. President
Stephen Chun announced the committee
assignments for 1991; the Board's four
committees are administration/person-
nel, enforcement, examination/licensing,
and regulation/legislation. Legal counsel
suggested that the Board limit the com-
mittees to two members if it wishes to
avoid the public meeting requirement.
FUTURE MEETINGS:
August 22-23 in San Francisco.
November 18-19 in Los Angeles.
BOARD OF PHARMACY
Executive Officer: Patricia Harris
(916) 445-5014
Pursuant to Business and Professions
Code section 4000 et seq., the Board of
Pharmacy grants licenses and permits to
pharmacists, pharmacies, drug manufac-
turers, wholesalers and sellers of hypo-
dermic needles. It regulates all sales of
dangerous drugs, controlled substances
and poisons. The Board is authorized to
adopt regulations, which are codified in
Division 17, Title 16 of the California
Code of Regulations (CCR). To enforce
its regulations, the Board employs full-
time inspectors who investigate accusa-
tions and complaints received by the
Board. Investigations may be conducted
openly or covertly as the situation
demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, includ-
ing professional misconduct and any acts
substantially related to the practice of
pharmacy.
The Board consists of ten members,
three of whom are public. The remaining
members are pharmacists, five of whom
must be active practitioners. All are
appointed for four-year terms.
At the Board's January 30 meeting,
Board President Robert Toomajian intro-
duced three new Board members: phar-
macists Janeen McBride of Thousand
Oaks and Raffi Simonian of San Diego,
and public member Herbert Stoecklein
of San Diego.
MAJOR PROJECTS:
Senate Studies Decline of Neighbor-
hood Pharmacies. On January 14, the
Senate Select Committee on Small Busi-
ness Enterprises conducted a hearing
entitled "The Decline of the Neighbor-
hood Pharmacies: At What Cost?" The
main concern of the Committee is the
decline of the neighborhood pharmacy
and its impact on the consumer's access
to pharmaceutical services.
At the hearing, many reasons were
suggested for the decline, including
The California Regulatory Law Reporter Vol. 11, No. 2 (Spring 19
REGULATORY AGENCY ACTION
competition with chain drug stores, mail
order pharmacies, and competitive pric-
ing. Board Executive Officer Patricia
Harris testified regarding mail order
pharmacies, noting that although the
Board does not license these pharmacies,
they must register with the Board, main-
tain a toll-free number which is affixed
to the prescription container, comply
with the Board's triplicate prescription
requirements, and be able to readily
retrieve their records on California resi-
dents.
As a result of the hearing, Board staff
expects the Committee to establish a
task force to research the relevant issues
and possibly propose legislation to
address any problem areas.
Nuclear Pharmacy. During its Jan-
uary meeting, at the request of the direc-
tors of nuclear medicine and radiophar-
macy at UCLA and USC, the Board
again considered the potential confusion
between the Food and Drug Administra-
tion's regulation of the drug aspects of
nuclear medicine, the Nuclear Regulato-
ry Commission's jurisdiction over pos-
session and handling of all radioactive
materials, and guidelines for medical
licensees established by the California
Radiologic Health Branch (RHB) of the
Department of Health Services. The
nuclear medicine practitioners contend
that because the radiopharmacist is high-
ly specialized and qualified, the CCR
provisions pertinent to pharmacists pro-
mulgated by the Board should also apply
to radiopharmacists. Currently, radio-
pharmacists are required to comply with
the far more detailed and time-consum-
ing guidelines which RHB prepares. The
Board is concerned that new regulatory
changes which RHB has proposed may
infringe upon the practice of pharmacy.
Nonetheless, as conditions currently
stand, the Board recognizes that RHB
has full authority to propose regulations
governing nuclear pharmacy.
Pharmacist Shortage. At its January
meeting, the Board rejected implementa-
tion of the NABPLEX (National Associ-
ation of Boards of Pharmacy Licensure
Examination), at the recommendation of
its Competency Committee. Use of the
exam would enable the Board to consid-
er granting reciprocity licensure to out-
of-state pharmacists, to resolve an appar-
ent shortage of licensed pharmacists in
California. (See CRLR Vol. 11, No. I
(Winter 1991) p. 82 and Vol. 10, No. 4
(Fall 1990) p. 99 for background infor-
mation.) The Board felt that the items
used in the sample NABPLEX were not
as practice-oriented as those in the Cali-
fornia exam; also, the exam has potential
security problems in that it is not admin-
istered under consistent conditions
among states. The Board felt these prob-
lems would result in incomparable test
scores and thus defeat he goal of license
reciprocity. Further, California would
have to administer its own essay exam,
thereby increasing the overall cost to
applicants.
Impaired Pharmacist Program. In
January, the Board's Impaired Pharma-
cist Liaison Committee reviewed its
structure and goals, and presented rec-
ommendations for changes to the
Board's Impaired Pharmacist Program
for drug- and alcohol-abusing pharma-
cists. These recommendations, which
include extension of the program indefi-
nitely and the renaming of the program
to "Pharmacist Recovery Program,"
have been incorporated into AB 1893
(Lancaster) (see infra LEGISLATION).
Since its inception in 1985, 240 phar-
macists have participated in the pro-
gram, with 58 successful completions
and one relapse. One-third of the partici-
pants withdrew from the program volun-
tarily prior to completion; program
directors attribute this attrition rate to the
extensive follow-up and work involved
in the program. The Board continues to
investigate discipline violations during a
pharmacist's participation in the pro-
gram.
Long-Term Care Facilities. At its
January 30 meeting, the Board consid-
ered a petition for rulemaking from
Amcare, a pharmacy which services
long-term and skilled nursing facilities.
Amcare requested the adoption of regu-
lations for separate licensure of and spe-
cial packaging requirements for long-
term care pharmacies. Amcare also
sought regulations which would modify
personnel requirements to allow for use
of non-licensed technicians to assist each
pharmacist in dispensing and packaging
of medications; and allow a long-term
care facility pharmacy, when dispensing
a prescription in unit dose or modified
unit dose form, to use the expiration date
on the manufacturer's package unless it
can be shown that the unit dose repack-
aging process harms the effectiveness or
potency of the drug. Amcare, on behalf
of itself and other long-term care facili-
ties, argued that the distinctions in the
type of care provided by long-term care
pharmacies justify different regulations;
long-term care pharmacies are closed to
the public and therefore have no direct
contact with consumers.
The Board's counsel determined that
the Board lacks authority to create a sep-
arate license category. Further, counsel
noted that the Board is addressing the
issue of pharmacy technicians in pend-
ing legislation. Amcare agreed to with-
draw its petition, and the Board's presi-
dent agreed to establish a committee to
study the special needs of pharmacies
serving long-term care facilities.
Investigation of Revenue Enhance-
ment Programs Between Physicians and
Home IV Providers. The Board is contin-
uing to gather information from pharma-
cists and other sources regarding fee
arrangements between physicians and
home infusion companies. (See CRLR
Vol. 11, No. 1 (Winter 1991) p. 82 and
Vol. 10, No. 4 (Fall 1990) pp. 98-99 for
background information.) The Board
expects to fully discuss this issue at its
July 30 meeting.
Board Submits Report on Prescriber
Dispensing Complaints. As required by
AB 1732 (Isenberg) (Chapter 1600,
Statutes of 1988), the Board submitted a
report to the legislature in January on
complaints involving prescriber dispens-
ing. (See CRLR Vol. 8, No. 4 (Fall 1988)
p. 70 for background information.) AB
1732 requires the Board to forward all
complaints relating to drugs or danger-
ous devices dispensed under the provi-
sions of AB 1732 to the Medical Board
of California (MBC). In addition, the bill
requires that MBC handle those com-
plaints involving serious bodily injury as
a case of greatest potential harm to a
patient.
The report states that from August 1,
1988, through December 27, 1990, the
Board received 31 complaints concern-
ing improper dispensing by licens-
ed physicians. Of the 31 complaints
referred to MBC, the Board has received
disposition information on 22 of the
referrals; however, the report does not
note the nature of the dispositions. The
Board has not received disposition infor-
mation on the remaining nine com-
plaints; MBC claims that the complaints
are not listed in its complaint tracking
system and therefore MBC has no record
of their receipt. The Board plans to meet
with MBC to discuss a procedure where-
by complaints referred from the Board of
Pharmacy will be registered in MBC's
enforcement complaint tracking system
so that they may be accurately tracked
and appropriately investigated.
Proposed Regulatory Changes. The
following is a status update on numerous
regulatory changes considered by the
Board in recent months. (See CRLR Vol.
11, No. I (Winter 1991) pp. 82-83; Vol.
10, No. 4 (Fall 1990) pp. 99-100; and
Vol. 10, Nos. 2 & 3 (Spring/Summer
1990) pp. 114-115 for extensive back-
ground information on these changes.)
-Pharmacy Technicians. On January
3, the Governor's Office denied the
Board's request to overturn the Office of
Administrative Law's (OAL) disapproval
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of the pharmacy technician rulemak-
ing file; OAL had rejected for the third
time the Board's proposed section 1717,
for failure to comply with the consisten-
cy standard of Government Code section
11349.1. The Board has proposed legis-
lation which would allow the use of
pharmacy technicians (see infra LEGIS-
LATION).
-Oral Consultation. On January 11,
OAL granted the Board's request to
delay implementation of new sections
1707.1 and 1707.2 until January 1, 1992.
The Board sought the delay to provide
pharmacists with additional time to pre-
pare for and phase in the changes to
pharmacy practice mandated by the new
oral consultation regulations.
The Board is also concerned about
application of these new regulations to
out-of-state mail order services; in Jan-
uary, the California Pharmacists Associ-
ation (CPhA) notified the Board regard-
ing its view that mail order dispensers,
as well as traditional community phar-
macies, should be required to comply
with the regulations. Possible sugges-
tions for application include requiring
mandatory 24-hour hotlines for oral con-
sultation; requiring mail order dis-
pensers to provide written information
with the prescription; or requiring them
to include a written notice informing the
patient that consultation is available and
is a requirement under California law.
CPhA may also seek federal legislation
requiring pharmacies providing services
to out-of-state patients to meet the
requirements set forth by each state.
-Preprinted, Multiple Check-off Pre-
scription Pads. On January 3, OAL
approved new section 1717.3, which
went into effect in February. The regula-
tion specifies that only one prescription
may be prescribed from a single
preprinted prescription form, and no
controlled substances may be prescribed
on a preprinted form.
-English Equivalency Examination.
On January 24, OAL approved the
Board's amendment to section 1719,
which reflects the specific pass score on
the Test of Spoken English. The regula-
tion applies to foreign-trained pharma-
cists and is scheduled to become effec-
tive in June.
-Continuing Education Advertising.
On January 30, the Board held a regula-
tory hearing on proposed amendments to
section 1732.3(d), pertaining to continu-
ing education advertising. Following the
hearing, the Board adopted the proposed
amendment subject to a minor technical
change in the regulatory proposal
(changing "accredited program" to
"approved program"), and re-released
the regulation for an additional 15-day
comment period. The Board expected to
submit the rulemaking package to OAL
in April.
-Pharmacist-In-Charge. On February
5, OAL approved new section 1709.1,
regarding the designation of a pharma-
cist-in-charge at each pharmacy.
-Processing Times for Applications
and Registrations. Proposed new section
1706.1 of the CCR specifies the process-
ing times within which the Board will
process applications, pursuant to the Per-
mit Reform Act of 1981, Government
Code section 15374 et seq. The Board
adopted the regulation at an October
1990 public hearing and is preparing to
submit the regulation to the Department
of Consumer Affairs (DCA) for review.
If approved by DCA, the rulemaking file
will be submitted with OAL for
approval.
-Compounding for Office Use. The
Board was scheduled to hold a public
hearing at its May meeting concerning
proposed modifications to regulatory
sections 1716.1 and 1716.2, regarding
the definition of the phrase "reasonable
quantity of compounded medication"
under Business and Professions Code
section 4046(c)(1). The proposed regula-
tions would specify the minimum
records that must be kept for those phar-
macies which compound medication for
prescribers' office use.
LEGISLATION:
AB 1226 (Hunter). Existing law, with
certain exceptions, authorizes a pharma-
cist filling a prescription order for a drug
product prescribed by its trade or brand
name to select another drug product with
the same active chemical ingredients of
the same strength, quantity, and dosage
form, and of the same generic drug type.
Existing law also requires the Director of
the Department of Health Services
(DHS) to establish a formulary of gener-
ic drug types and drug products which
the Director determines demonstrate
clinically significant biological or thera-
peutic inequivalence and which, if sub-
stituted, would pose a threat to the health
and safety of patients receiving medica-
tion if that medication is substituted by a
pharmacist in lieu of a brand name drug
prescribed by a prescriber. As introduced
March 6, this bill would change the stan-
dard to be applied by the Director in
establishing the formulary to instead
apply to those generic drug types and
drug products which, if substituted as
described above, may pose a threat to the
health and safety of patients. This bill
would also require the Director to con-
sider all information submitted by any
person who requests that the Director
make any inclusion, addition, or deletion
of a generic drug type or drug product to
the formulary. This bill is pending in the
Assembly Health Committee.
AB 1253 (Baker). Under existing law,
there are various regulations regarding
medical devices, including a require-
ment that no person other than a regis-
tered or intern pharmacist or other autho-
rized person may enter an area, place, or
premises wherein specified devices are
stored, possessed, prepared, manufac-
tured, derived, compounded, or repack-
aged. As introduced March 6, this bill
would provide that none of these regula-
tions should be construed to prevent the
storage of medical devices in secure cen-
tral or ward supply areas of clinics, hos-
pitals, institutions, or of the California
Rehabilitation Center or certain facilities
or institutions for judicial commitments.
This bill is pending in the Assembly
Health Committee.
AB 1371 (Wright). Existing law pro-
hibits any person from conducting a
pharmacy or medical device retailer
unless he/she has obtained a certificate,
license, permit, or registration from the
Board. For those purposes, a medical
device retailer does not include any area
in a facility licensed by DHS where floor
supplies, ward supplies, operating room
supplies, or emergency room supplies of
dangerous devices are stored or pos-
sessed solely for certain treatment pur-
poses. As introduced March 7, this bill
would add home care supplies to this
exemption list and would add the treat-
ment of patients at home by a licensed
home health agency within the permitted
treatment purposes. This bill is pending
in the Assembly Health Committee.
AB 1893 (Lancaster), as introduced
March 8, would revise the applicability
of pharmacy laws with respect to certain
medical supplies; and retitle the
Impaired Pharmacist Program, sched-
uled for repeal on January 1, 1992, as the
Pharmacist Recovery Program and con-
tinue its provisions indefinitely. This bill
is pending in the Assembly Committee
on Consumer Protection, Governmental
Efficiency, and Economic Development.
SB 1033 (Marks). Existing law
declares the practice of pharmacy to be a
profession, and specifies certain activi-
ties which a pharmacist is permitted to
do, including but not limited to manufac-
turing, measuring, fitting to the patient,
or selling and repairing legend medical
devices or furnishing instructions to the
patient. As introduced March 8, this bill
would modify this authority to permit
pharmacists to do manufacturing, mea-
suring, fitting to the patient, or selling
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and repairing medical devices without
regard to whether they bear a specified
legend relating to a federal law prohibi-
tion against dispensing without a pre-
scription. This bill is pending in the Sen-
ate Business and Professions Committee.
AB 855 (Hunter), as introduced
February 27, would provide that
notwithstanding any other provision of
law, no pharmacist in filling a prescrip-
tion for a drug product described by its
trade or brand name shall select another
drug product pursuant o these provi-
sions if the federal Secretary of Health
and Human Services or the federal Com-
missioner of Food and Drugs has
proposed to withdraw the generic drug
from the market and has issued a notice
of opportunity for a hearing because the
drug lacks substantial evidence of effec-
tiveness for all labeled indications and
for which the Secretary or Commission-
er has made no determination that there
is compelling justification for its medi-
cal need. This bill is pending in the
Assembly Health Committee.
AB 1244 (Polanco). Existing law,
with specified exceptions, makes it
unlawful for any person to manufacture,
compound, sell, or dispense any danger-
ous drug or devices, or to dispense or
compound any prescription of a medical
practitioner unless he/she is a registered
pharmacist. As introduced March 6, this
bill would exclude from this registration
requirement any nonlicensed pharmacy
personnel engaged in performing cleri-
cal, inventory, packaging, and dispens-
ing related tasks while assisting, and
while under the direct supervision of, a
registered pharmacist. The Board previ-
ously attempted to accomplish this
change by rulemaking; however, the
Office of Administrative Law rejected
the proposal on three separate occasions,
determining that the Board's proposal
was inconsistent with federal and state
law. (See CRLR Vol. 11, No. I (Winter
1991) p. 83 for background informa-
tion.) This bill is pending in the Assem-
bly Health Committee.
SB 917 (Kopp), as introduced March
8, would require any health care service
plan that proposes to offer a pharmacy
benefit or proposes to change its rela-
tionship with pharmacy providers to
give written or published notice to phar-
macy service providers of the plan's pro-
posal and give those providers an oppor-
tunity to submit a bid to participate in
the plan's panel of providers on the
terms proposed. This bill is pending in
the Senate Committee on Insurance,
Claims and Corporations.
AB 1675 (Margolin), as introduced
March 8, would require the Board to
designate a statewide drug information
center for the purpose of offering direct
telephone assistance or referral to health
care providers for any person desiring
information relating to prescription
drugs. This bill would require the center
to be under the direction of a person,
appointed by the Board, who is licensed
under the provisions of law relative to
the healing arts and who is experienced
in providing drug information to the
public; that person would be required to
comply with requirements and criteria of
the Board regarding operation of the
center. The bill would require the Board
to provide on license renewal forms an
opportunity to make voluntary contribu-
tions for purposes of the statewide drug
information center. This bill is pending
in the Assembly Health Committee.
AB 819 (Speier). Existing law pro-
vides that, except as otherwise specified,
the offer, delivery, receipt, or acceptance
by prescribed licensed health profession-
als of any rebate, refund, commission,
preference, patronage dividend, dis-
count, or other consideration, whether in
the form of money or otherwise, as com-
pensation or inducement for referring
patients, clients, or customers to any per-
son is unlawful, punishable as a misde-
meanor or felony. Existing law also pro-
vides that it is not unlawful for a person
to refer a person to a laboratory, pharma-
cy, clinic, or health care facility solely
because the licensee has a proprietary
interest or coownership in the facility.
As introduced February 27, this bill
would, effective July 1, 1992, delete the
exception for proprietary or coownership
interests, and instead provide that it is
unlawful for these licensed health pro-
fessionals to refer a person to any labora-
tory, pharmacy, clinic, or health care
facility which is owned in whole or in
part by the licensee or in which the
licensee has a proprietary interest; the
bill would also provide that disclosure of
the ownership or proprietary interest
would not exempt the licensee from the
prohibition. However, the bill would
permit specified licensed health profes-
sionals to refer a person to a laboratory,
pharmacy, clinic, or health care facility
which is owned in whole or in part by
the licensee or in which the licensee has
a proprietary interest if the person
referred is the licensee's patient of
record, there is no alternative provider or
facility available, and to delay or forego
the needed health care would pose an
immediate health risk to the patient. This
bill is pending in the Assembly Health
Committee.
SB 594 (Roberti), as introduced
March 4, would require the State Depart-
ment of Alcohol and Drug Programs and
the Department of Aging to jointly
administer a statewide roundtable to
develop a consistent, long-term medica-
tion education program model for elder-
ly consumers. This bill is pending in the
Senate Committee on Health and Human
Services.
FUTURE MEETINGS:
July 30-August 1 in Sacramento.
October 16-17 in Los Angeles.
BOARD OF REGISTRATION FOR
PROFESSIONAL ENGINEERS
AND LAND SURVEYORS
Executive Officer: Darlene Stroup
(916) 920-7466
The Board of Registration for Profes-
sional Engineers and Land Surveyors
(PELS) regulates the practice of engi-
neering and land surveying through its
administration of the Professional Engi-
neers Act, sections 6700 through 6799 of
the Business and Professions Code, and
the Professional Land Surveyors' Act,
sections 8700 through 8805 of the Busi-
ness and Professions Code. The Board's
regulations are found in Division 5, Title
16 of the California Code of Regulations
(CCR).
The basic functions of the Board are
to conduct examinations, issue certifi-
cates, registrations, and/or licenses, and
appropriately channel complaints against
registrants/licensees. The Board is
additionally empowered to suspend or
revoke registrations/licenses. The Board
considers the proposed decisions of
administrative law judges who hear
appeals of applicants who are denied a
registration/license, and those who have
had their registration/license suspended
or revoked for violations.
The Board consists of thirteen mem-
bers: seven public members, one
licensed land surveyor, four registered
Practice Act engineers and one Title Act
engineer. Eleven of the members are
appointed by the Governor for four-year
terms which expire on a staggered basis.
One public member is appointed by the
Speaker of the Assembly and one by the
Senate President pro Tempore.
The Board has established four stand-
ing committees and appoints other spe-
cial committees as needed. The four
standing committees are Administration,
Enforcement, Examination/Qualifica-
tions, and Legislation. The committees
function in an advisory capacity unless
specifically authorized to make binding
decisions by the Board.
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